Neuroendocrine differentiation in prostate cancer
Jiaoti Huang
摘要： The treatment of choice for advanced/metastatic prostate cancer(PC) is hormonal therapy. Although patients respond initially to this therapy, the tumor will recur and enter the androgen-independent state, which is the major obstacle in therapy.
机标关键词：
分类号：R73(肿瘤学)
论文发表日期：2008-03-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：1( 106 )